• Bangalore
  • 14 December 2012
  • Interviews
  • By Rahul Koul

Mr Trehan: We will be launching new product lines in proteomics and genomics

Mr Navneet Trehan, CEO, GenAxy Scientific speaks about the company's performance, product additions, future outlook and bio supplier market trends


Mr Navneet Trehan, CEO, GenAxy Scientific, New Delhi

Started in 1999, GenAxy Scientific with its corporate office in New Delhi and head office in Solan, has made a mark in offering wide product range in plasticware and instrumentation. Equipped with customer friendly, motivated, well learned, qualified and trained personnel in all the departments, and well organized distribution channels comprising of five branch offices and 184 distributors, the company in 2011-12 recorded a revenue of Rs34 crore and has shown consistent growth over the period of time. Its sister concern Future Biosciences too has made significant development in lab consumables business by registering close to Rs5 crore revenue in the last fiscal.

In an interaction with BioSpectrum, Mr Navneet Trehan, CEO, GenAxy Scientific talks among other things, the factors which hamper the growth of biosuppliers.

How do you measure the performance of GenAxy Scientific in the last year? How have things unfolded for Future Biosciences?

The performance of GenAxy in the past year has been excellent. New product lines and extended range of existing products has increased our credibility to many folds. We started offering robotic systems with high-end customized and innovative solutions. This venture is in collaboration with the state-of-the-art technology from Aurora Biomed, Canada and Arise, Taiwan.

Started in 2005, Future Bioscience (FBS) has made its presence felt in the Indian market. The company has been registered among the top 50 companies in India in the past two years. Strategic and strong tie-ups with Bisicion, Cleaver Scientific, Grant, and TPP have made FBS a reliable supplier to the scientific fraternity, besides the launch of indigenous range of plastic consumables.

How do you differentiate yourself in the competitive biosupplier market?

We have extended our operations in proteomics. We are now launching the magnetic beads technology from Axygen. It is going to contribute in a big way in the coming months. We will be launching many new product lines in proteomics and genomics in next six months, after we stabilize our new range of products such as 15/50 ml tubes and the other plasticware range.

GenAxy has also launched platelet incubators and a complete range of autoclaves from Nuve. We will also be launching a range of incubators such as shaking incubators and refrigerated shaking incubators.

Customers' satisfaction through business ethics makes us different in the competitive market. We value our relationship with scientific fraternity and prove it by giving them world class products and best sale services.



Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email